Skip to main
  1. Stocks
  2. Cohen & Steers
  3. Forecast
CNS

CNS Stock Forecast & Price Target

CNS Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%
CNS has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cohen & Steers and is not a guaranteed prediction by Public.com or investment advice.

CNS Analyst Forecast & Price Prediction

Get the latest CNS stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in CNS

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cohen & Steers (CNS) Forecast

Analysts have given CNS a Buy based on their latest research and market trends.

According to 1 analysts, CNS has a Buy consensus rating as of Oct 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cohen & Steers (CNS)


CNS Analyst Forecast & Price Prediction

Get the latest CNS stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in CNS

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover CNS stock data and trends